161 related articles for article (PubMed ID: 24382891)
21. Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway.
Zou ZV; Gul N; Lindberg M; Bokhari AA; Eklund EM; Garellick V; Patel AAH; Dzanan JJ; Titmuss BO; Le Gal K; Johansson I; Tivesten Å; Forssell-Aronsson E; Bergö MO; Staffas A; Larsson E; Sayin VI; Lindahl P
Sci Rep; 2020 Aug; 10(1):14156. PubMed ID: 32843651
[TBL] [Abstract][Full Text] [Related]
22. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
Miao L; Song Z; Jin L; Zhu YM; Wen LP; Wu M
Oncogene; 2010 Feb; 29(5):711-22. PubMed ID: 19901969
[TBL] [Abstract][Full Text] [Related]
23. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
24. Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3.
Maris JM; Jensen SJ; Sulman EP; Beltinger CP; Gates K; Allen C; Biegel JA; Brodeur GM; White PS
Genomics; 1996 Jul; 35(2):289-98. PubMed ID: 8661141
[TBL] [Abstract][Full Text] [Related]
25. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.
Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384
[TBL] [Abstract][Full Text] [Related]
26. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of ARF regulation that control senescence and cancer.
Ko A; Han SY; Song J
BMB Rep; 2016 Nov; 49(11):598-606. PubMed ID: 27470213
[TBL] [Abstract][Full Text] [Related]
28. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
29. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
30. ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4.
Dominguez-Brauer C; Chen YJ; Brauer PM; Pimkina J; Raychaudhuri P
EMBO Rep; 2009 Sep; 10(9):1036-42. PubMed ID: 19644500
[TBL] [Abstract][Full Text] [Related]
31. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
[TBL] [Abstract][Full Text] [Related]
32. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
33. Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent.
Chew YC; Adhikary G; Wilson GM; Xu W; Eckert RL
J Biol Chem; 2012 May; 287(20):16168-78. PubMed ID: 22427654
[TBL] [Abstract][Full Text] [Related]
34. RUVBL2 is a novel repressor of ARF transcription.
Xie C; Wang W; Yang F; Wu M; Mei Y
FEBS Lett; 2012 Feb; 586(4):435-41. PubMed ID: 22285491
[TBL] [Abstract][Full Text] [Related]
35. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
[TBL] [Abstract][Full Text] [Related]
36. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
Kamrul HM; Wadhwa R; Kaul SC
Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
[TBL] [Abstract][Full Text] [Related]
37. Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
Carrasco-Garcia E; Arrizabalaga O; Serrano M; Lovell-Badge R; Matheu A
Aging Cell; 2015 Aug; 14(4):710-4. PubMed ID: 25990896
[TBL] [Abstract][Full Text] [Related]
38. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of Bmi-1-responding element within the human p16 promoter.
Meng S; Luo M; Sun H; Yu X; Shen M; Zhang Q; Zhou R; Ju X; Tao W; Liu D; Deng H; Lu Z
J Biol Chem; 2010 Oct; 285(43):33219-33229. PubMed ID: 20551323
[TBL] [Abstract][Full Text] [Related]
40. Akt phosphorylates myc-associated zinc finger protein (MAZ), releases P-MAZ from the p53 promoter, and activates p53 transcription.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Cancer Lett; 2016 May; 375(1):9-19. PubMed ID: 26902421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
